These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31734955)

  • 21. Price and income elasticities of demand for modern health care: the case of infant delivery in the Philippines.
    Schwartz JB; Akin JS; Popkin BM
    World Bank Econ Rev; 1988 Jan; 2(1):49-76. PubMed ID: 12282273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pricing and reimbursement of pharmaceuticals in the Czech Republic and Sweden.
    Davidova J; Praznovcova L; Lundborg CS
    Pharm World Sci; 2008 Jan; 30(1):57-64. PubMed ID: 17588212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Most Americans Do Not Believe That There Is An Association Between Health Care Prices And Quality Of Care.
    Phillips KA; Schleifer D; Hagelskamp C
    Health Aff (Millwood); 2016 Apr; 35(4):647-53. PubMed ID: 27044965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug price transparency initiative: A scoping review.
    Ahmad NS; Makmor-Bakry M; Hatah E
    Res Social Adm Pharm; 2020 Oct; 16(10):1359-1369. PubMed ID: 31987771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Population policy.
    Asia Pac Popul J; 1987 Mar; 2(1):57-64. PubMed ID: 12341036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Price negotiation and pricing of anticancer drugs in China: An observational study.
    Zhou J; Lan T; Lu H; Pan J
    PLoS Med; 2024 Jan; 21(1):e1004332. PubMed ID: 38166148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and Extent of Institutional Trust in Government, Banks, the Media and Religious Organisations: Evidence from Cross-Sectional Surveys in Six Asia-Pacific Countries.
    Ward PR; Miller E; Pearce AR; Meyer SB
    PLoS One; 2016; 11(10):e0164096. PubMed ID: 27701439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formal Implementation of Cost-Effectiveness Evaluations in Japan: A Unique Health Technology Assessment System.
    Hasegawa M; Komoto S; Shiroiwa T; Fukuda T
    Value Health; 2020 Jan; 23(1):43-51. PubMed ID: 31952673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A health plan work in progress: hospital-physician price and quality transparency.
    Tynan A; Liebhaber A; Ginsburg PB
    Res Brief; 2008 Aug; (7):1-8. PubMed ID: 18831095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translating Research to Policy: Setting Provider Payment Rates for Strategic Purchasing under India's National Publicly Financed Health Insurance Scheme.
    Prinja S; Singh MP; Rajsekar K; Sachin O; Gedam P; Nagar A; Bhargava B;
    Appl Health Econ Health Policy; 2021 May; 19(3):353-370. PubMed ID: 33462775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
    Rand LZ; Kesselheim AS
    J Law Med Ethics; 2020 Sep; 48(3):583-594. PubMed ID: 33021189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US.
    Horný M; Shafer PR; Dusetzina SB
    JAMA Netw Open; 2021 Dec; 4(12):e2137390. PubMed ID: 34902037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Price and consumer cost responsibility effects on quality perceptions and price negotiation likelihood for healthcare services.
    Carlson JP; Huppertz JW; Neidermeyer PE
    Health Mark Q; 2008; 25(4):303-28. PubMed ID: 19064474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of healthcare cost accounting in pricing and reimbursement in low-income and middle-income countries: a scoping review.
    Guinness L; Ghosh S; Mehndiratta A; Shah HA
    BMJ Open; 2022 Sep; 12(9):e065019. PubMed ID: 36171039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pricing and imperfections in the medical care marketplace.
    Newhouse JP
    Dev Health Econ Public Policy; 1992; 1():3-22. PubMed ID: 10151751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "It's not a one operation fits all": A qualitative study exploring fee setting and participation in price transparency initiatives amongst medical specialists in the Australian private healthcare sector.
    Sabanovic H; La Brooy C; Méndez SJ; Yong J; Scott A; Elshaug AG; Prang KH
    Soc Sci Med; 2023 Dec; 339():116353. PubMed ID: 37988804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland.
    Michaeli DT; Mills M; Kanavos P
    Appl Health Econ Health Policy; 2022 Sep; 20(5):757-768. PubMed ID: 35821360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness research and evidence-based health policy: experience from four countries.
    Chalkidou K; Tunis S; Lopert R; Rochaix L; Sawicki PT; Nasser M; Xerri B
    Milbank Q; 2009 Jun; 87(2):339-67. PubMed ID: 19523121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of cross-reference pricing on pharmaceutical prices: manufacturers' pricing strategies and price regulation.
    Stargardt T; Schreyögg J
    Appl Health Econ Health Policy; 2006; 5(4):235-47. PubMed ID: 17249840
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.